Approval · Notice of Compliance 26 · 2003
AXERT: Notice of Compliance 26
Issued September 29, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26
- Date
- September 29, 2003
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- 5-ht1, receptor agonist - migraine therapy
Products in this notice
Medicinal ingredients
- ALMOTRIPTAN MALATE 6.25 MG per TAB
- ALMOTRIPTAN MALATE 12.5 MG per TAB